MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹6,848 Cr | ₹5,791 Cr | ₹457 Cr | ₹44,272 Cr | ₹4,055 Cr |
What is the latest Total Expenditure of MANKIND PHARMA ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹6,848 Cr |
Mar2023 | ₹5,791 Cr |
Mar2022 | ₹457 Cr |
Mar2021 | ₹44,272 Cr |
Mar2020 | ₹4,055 Cr |
How is Total Expenditure of MANKIND PHARMA Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹6,848 Cr | 18.24 | |
Mar2023 | ₹5,791 Cr | 1,168.48 | |
Mar2022 | ₹457 Cr | -98.97 | |
Mar2021 | ₹44,272 Cr | 991.79 | |
Mar2020 | ₹4,055 Cr | - |
Compare Total Expenditure of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹97,083.5 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,076.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.4% |
-7.8% |
9.9% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses